The University of Southampton
University of Southampton Institutional Repository

Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?

Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?
Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?
Human variability in the kinetics of CYP2D6 substrates has been quantified using a database of compounds metabolised extensively (>60%) by this polymorphic enzyme. Published pharmacokinetic studies (after oral and intravenous dosing) in non-phenotyped healthy adults, and phenotyped extensive (EMs), intermediate or slow-extensive (SEMs) and poor metabolisers (PMs) have been analysed using data for parameters that relate primarily to chronic exposure (metabolic and total clearances, area under the plasma concentration time-curve) and primarily to acute exposure (peak concentration). Similar analyses were performed with the available data for subgroups of the population (age, ethnicity and disease). Interindividual differences in kinetics for markers of oral exposure were large for non-phenotyped individuals and for EMs (coefficients of variation were 67–71% for clearances and 54–63% for Cmax), whereas the intravenous data indicated a lower variability (34–38%).
Comparisons between EMs, SEMs and PMs revealed an increase in oral internal dose for SEMs and PMs (ratio compared to EMs=3 and 9–12, respectively) associated with lower variability than that for non-phenotyped individuals (coefficients of variation were 32–38% and 30% for SEMs and PMs, respectively). In relation to the uncertainty factors used for risk assessment, most subgroups would not be covered by the kinetic default of 3.16. CYP2D6-related factors necessary to cover 95–99% of each subpopulation ranged from 2.7 to 4.1 in non-phenotyped healthy adults and EMs to 15–18 in PMs and 22–45 in children. An exponential relationship (R2=0.8) was found between the extent of CYP2D6 metabolism and the uncertainty factors. The extent of CYP2D6 involvement in the metabolism of a substrate is critical in the estimation of the CYP2D6-related factor. The 3.16 kinetic default factor would cover PMs for substrates for which CYP2D6 was responsible for up to 25% of the metabolism in EMs.
human variability, pharmacokinetics, cyp2d6, uncertainty factors, risk assessment, sensitive subgroups
0278-6915
1633-1656
Dorne, J.L.C.M.
bb24d5c7-c4fd-445a-9785-0a03d216fdc2
Walton, K.
024c9ff2-0a40-4fda-a213-db73d9971871
Slob, W.
60123ddc-7aff-4c5e-8a32-f5924cb53162
Renwick, A.G.
596705ab-5418-4e02-9ad7-c4309326df46
Dorne, J.L.C.M.
bb24d5c7-c4fd-445a-9785-0a03d216fdc2
Walton, K.
024c9ff2-0a40-4fda-a213-db73d9971871
Slob, W.
60123ddc-7aff-4c5e-8a32-f5924cb53162
Renwick, A.G.
596705ab-5418-4e02-9ad7-c4309326df46

Dorne, J.L.C.M., Walton, K., Slob, W. and Renwick, A.G. (2002) Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? Food and Chemical Toxicology, 40 (11), 1633-1656. (doi:10.1016/S0278-6915(02)00117-5).

Record type: Article

Abstract

Human variability in the kinetics of CYP2D6 substrates has been quantified using a database of compounds metabolised extensively (>60%) by this polymorphic enzyme. Published pharmacokinetic studies (after oral and intravenous dosing) in non-phenotyped healthy adults, and phenotyped extensive (EMs), intermediate or slow-extensive (SEMs) and poor metabolisers (PMs) have been analysed using data for parameters that relate primarily to chronic exposure (metabolic and total clearances, area under the plasma concentration time-curve) and primarily to acute exposure (peak concentration). Similar analyses were performed with the available data for subgroups of the population (age, ethnicity and disease). Interindividual differences in kinetics for markers of oral exposure were large for non-phenotyped individuals and for EMs (coefficients of variation were 67–71% for clearances and 54–63% for Cmax), whereas the intravenous data indicated a lower variability (34–38%).
Comparisons between EMs, SEMs and PMs revealed an increase in oral internal dose for SEMs and PMs (ratio compared to EMs=3 and 9–12, respectively) associated with lower variability than that for non-phenotyped individuals (coefficients of variation were 32–38% and 30% for SEMs and PMs, respectively). In relation to the uncertainty factors used for risk assessment, most subgroups would not be covered by the kinetic default of 3.16. CYP2D6-related factors necessary to cover 95–99% of each subpopulation ranged from 2.7 to 4.1 in non-phenotyped healthy adults and EMs to 15–18 in PMs and 22–45 in children. An exponential relationship (R2=0.8) was found between the extent of CYP2D6 metabolism and the uncertainty factors. The extent of CYP2D6 involvement in the metabolism of a substrate is critical in the estimation of the CYP2D6-related factor. The 3.16 kinetic default factor would cover PMs for substrates for which CYP2D6 was responsible for up to 25% of the metabolism in EMs.

This record has no associated files available for download.

More information

Published date: 2002
Keywords: human variability, pharmacokinetics, cyp2d6, uncertainty factors, risk assessment, sensitive subgroups

Identifiers

Local EPrints ID: 27028
URI: http://eprints.soton.ac.uk/id/eprint/27028
ISSN: 0278-6915
PURE UUID: 1d697e83-0d80-46a7-86bf-8a70a25ede4c

Catalogue record

Date deposited: 26 Apr 2006
Last modified: 15 Mar 2024 07:15

Export record

Altmetrics

Contributors

Author: J.L.C.M. Dorne
Author: K. Walton
Author: W. Slob
Author: A.G. Renwick

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×